Search images on Google Product Monograph
Active Ingredients:
- recombinant neisseria meningitidis group b nhba fusion protein, 50 MCG/0.5 ML
- recombinant neisseria meningitidis group b nada protein, 50 MCG/0.5 ML
- recombinant neisseria meningitidis group b fhbp fusion protein, 50 MCG/0.5 ML
- outer membrane vesicles (neisseria meningitidis group b nz98/254 strain), 25 MCG/0.5 ML
DIN: 02417030
Dosage Form(s): SUSPENSION
Route(s) of Administration: INTRAMUSCULAR
Description: MULTICOMPONENT MENINGOC. B VACCINE (R-DNA ADSORBED). 0.5ML PFS.
Schedule: Schedule D
Company: GLAXOSMITHKLINE INC – official site
ATC:
- J07 - VACCINES (ATC, WHO, Wiki)
- J07A - BACTERIAL VACCINES (ATC, WHO)
- J07AH - Meningococcal vaccines (ATC, WHO)
- J07AH09 - MENINGOCOCCUS B, MULTICOMPONENT VACCINE (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1/10 PFS
External Links for Bexsero:
Search on Google
- Bexsero side effects
- Bexsero dosage
- recombinant neisseria meningitidis group b nhba fusion protein side effects
- recombinant neisseria meningitidis group b nhba fusion protein dosage
- recombinant neisseria meningitidis group b nada protein side effects
- recombinant neisseria meningitidis group b nada protein dosage
- recombinant neisseria meningitidis group b fhbp fusion protein side effects
- recombinant neisseria meningitidis group b fhbp fusion protein dosage
- outer membrane vesicles side effects
- outer membrane vesicles dosage
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find bexsero photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.